Rein Therapeutics, Inc. · NASDAQ:RNTX

BIOS EQUITY PARTNERS III, LP reported a 6.20% stake in Rein Therapeutics, Inc. (Schedule 13G)

Event May 5, 2025 · Filed Aug 11, 2025

BIOS EQUITY PARTNERS III, LP reported a 6.20% stake in Rein Therapeutics, Inc., 3,683,429 shares, as a passive investor on May 5, 2025. Filed Aug 11, 2025 (Schedule 13G).

Stake
6.20%
Shares
3,683,429
Intent
Passive
What changed
Crossed above 5%
Filed together
10 holders

The filing in full

HolderStakeShares
BIOS FUND III, LP0.70%430,665
BIOS FUND III QP, LP4.70%2,801,953
BIOS FUND III NT, LP0.80%450,811
BIOS EQUITY PARTNERS III, LP6.20%3,683,429
CAVU MANAGEMENT, LP6.20%3,683,429
BIOS CAPITAL MANAGEMENT, LP6.20%3,683,429
CAVU ADVISORS, LLC6.20%3,683,429
BIOS ADVISORS GP, LLC6.20%3,683,429
LESLIE WAYNE KREIS, JR.6.20%3,683,429
AARON GLENN LOUIS FLETCHER6.20%3,683,429

Source

View original at SEC

Related